APA (7th ed.) Citation

Haider, A., Gobbi, L., Kretz, J., Ullmer, C., Brink, A., Honer, M., . . . Ametamey, S. M. (2020). Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of medicinal chemistry, 63(18), 10287-10306. https://doi.org/10.1021/acs.jmedchem.0c00778

Chicago Style (17th ed.) Citation

Haider, Achi, et al. "Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors." Journal of Medicinal Chemistry 63, no. 18 (2020): 10287-10306. https://doi.org/10.1021/acs.jmedchem.0c00778.

MLA (9th ed.) Citation

Haider, Achi, et al. "Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors." Journal of Medicinal Chemistry, vol. 63, no. 18, 2020, pp. 10287-10306, https://doi.org/10.1021/acs.jmedchem.0c00778.